Altered Dosing of Vemurafenib Could Delay or Prevent Resistance

Researchers using a mouse model of melanoma were able to prevent resistance to vemurafenib by altering the dosing schedule from a continuous daily dose to an intermittent dose.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news